GGrantIndex
← Leaderboards

John W Crabb

Cleveland Clinic Foundation

$6,129,227
Attributed
$6,129,227
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $377.5K · FY200525
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,129,227 · 9

By mechanism

R01$2,540,173 · 2
R21$2,106,412 · 5
P30$1,482,642 · 2

Top collaborators

No co-investigators on record.

Most similar at Cleveland Clinic Foundation

Same institution · by research overlap

Others in their field

Top investigators on “Proteomics

Research focus

ProteomicsTissuesTechnologyProteinsGenomicsPost-Translational Protein ProcessingResourcesInsightComplexProtein Protein InteractionPrognosticVision ResearchVision ScienceMonitorBlindnessElderlyOxidative StressPlasmaTreatment EfficacyMass SpectrometryMolecularExperimental DesignsHigh Performance Liquid ChromatographyPlasma Proteins

Grant awards (22)

Core C Molecular Informatics Core$296,529
P30 · FY2025 · EY · contact PI
Core C Molecular Informatics Core$296,529
P30 · FY2024 · EY · contact PI
Core C Molecular Informatics Core$296,528
P30 · FY2023 · EY · contact PI
Core C Molecular Informatics Core$296,528
P30 · FY2022 · EY · contact PI
Core C Molecular Informatics Core$296,528
P30 · FY2021 · EY · contact PI
Proteomics of Metastatic and Non-Metastatic Uveal Melanoma$172,369
R21 · FY2018 · CA · contact PI
Proteomics of Metastatic and Non-Metastatic Uveal Melanoma$206,843
R21 · FY2017 · CA · contact PI
Carboxyethylpyrrole-Ethanolamine Phospholipids as AMD Biomarkers$198,125
R21 · FY2016 · EY · contact PI
Carboxyethylpyrrole-Ethanolamine Phospholipids as AMD Biomarkers$237,750
R21 · FY2015 · EY · contact PI
Proteomic Biomarkers for AMD$192,325
R21 · FY2014 · EY · contact PI
Proteomic Biomarkers for AMD$235,500
R21 · FY2013 · EY · contact PI
Biomarkers for Age-Related Macular Degeneration$196,250
R21 · FY2012 · EY · contact PI
Biomarkers for Age-Related Macular Degeneration$235,500
R21 · FY2011 · EY · contact PI
Proteomic Biomarkers for Primary Open Angle Glaucoma$196,250
R21 · FY2009 · EY · contact PI
Proteomic Biomarkers for Primary Open Angle Glaucoma$235,500
R21 · FY2008 · EY · contact PI
Proteomic Studies of Age Related Macular Degeneration$377,500
R01 · FY2005 · EY
Proteomic Studies of Age Related Macular Degeneration$370,000
R01 · FY2004 · EY
Proteomic Studies of Age Related Macular Degeneration$370,000
R01 · FY2003 · EY
Proteomic Studies of Age Related Macular Degeneration$370,000
R01 · FY2002 · EY
VISUAL CYCLE PROTEINS$355,399
R01 · FY2002 · EY
VISUAL CYCLE PROTEINS$349,668
R01 · FY2001 · EY
VISUAL CYCLE PROTEINS$347,606
R01 · FY2000 · EY